This study revealed the vital significance of CXCL16 in GC progression, implicating the ADAM10-dependent CXCL16/CXCR6 axis and might be a potential prognostic biomarker and therapeutic target in GC. This evidence concerns the gene CXCL16 and gastric cancer.